Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development a... Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements). 더 보기
LOS ANGELES, Aug. 08, 2024 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.5328 | -10.0097692944 | 5.3228 | 5.3599 | 4.75 | 39212 | 4.94871116 | CS |
4 | 0.3 | 6.68151447661 | 4.49 | 6.2899 | 4.23 | 72773 | 5.22890269 | CS |
12 | -0.44 | -8.41300191205 | 5.23 | 6.5 | 3.85 | 83092 | 4.83262539 | CS |
26 | -0.07 | -1.44032921811 | 4.86 | 6.96 | 3.8181 | 105711 | 5.27376752 | CS |
52 | -5.61 | -53.9423076923 | 10.4 | 11 | 3.8181 | 426604 | 7.39963846 | CS |
156 | -53.61 | -91.7979452055 | 58.4 | 102.6 | 3.8181 | 535235 | 29.19768624 | CS |
260 | -186.21 | -97.4921465969 | 191 | 356.4 | 3.8181 | 465069 | 53.95697585 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관